Gok M.A.; Malik K.I.; Jeff A.; Sadat M.M.; Ward S.J.; Khan U.A; Surgical Endoscopy and Other Interventional Techniques,

Emergency versus elective colorectal resections for malignancy: A single centre experience

Colorectal cancer is the 3rd most common malignancy in men & women in
the UK. Colorectal cancer presents as a surgical emergency in 30% of cases as
obstruction, perforation, abdominal pain, haemorrhage or sepsis. Emergency colorectal
cancer has been associated with high post-operative morbidity & mortality. The aim of
the study is to assess emergency colorectal malignant resections at a District General
Hospital.

This is a retrospective study carried out since January 2007 till September 2013 at Macclesfield District General Hospital.

Collection notes: Academic-License. Please when asked to pick an institution please pick
NHS. Please also note access is from 1997 to date only.

 

 

Continue reading

EY Tang, S Knight: Rheumatology; April 2014

This conference abstract on A local audit of pulmonary hypertension screening in systemic sclerosis in the north western region, written by Tang E.Y.; Knight S.

Citation: Rheumatology (United Kingdom), April 2014, vol./is. 53/(i118), 1462-0324 (April 2014)

Abstract: Background: Scleroderma, both limited and diffuse, can be associated with pulmonary hypertension. This can be life threatening. Licensed treatments are now available. In the North Western region, this rare condition is diagnosed and managed in conjunction with the Sheffield Pulmonary Hypertension Unit. This unit has developed national guidelines for screening for pulmonary hypertension in this patient group. This retrospective audit was to assess how well we comply with the guidelines and whether steps need to be taken to improve compliance.

Methods: Patients identified from Medisave programme by searching scleroderma, SSc, CREST. Proforma was designed based on the Sheffield guidelines.

Continue reading

Nausheen S.; Roberts A.J.; Wakefield N.; et al; BJOG; April 2014

Mode of delivery and perineal injury following primary obstetric anal sphincter injury
Citation: BJOG: An International Journal of Obstetrics and Gynaecology, April 2014, vol./is.
121/(228), 1470-0328 (April 2014)
Author(s): Nausheen S.; Roberts A.J.; Wakefield N.; Canavan L.; Dinardo L.

Abstract: Introduction Obstetric anal sphincter injury (OASI) complicates 1% of vaginal deliveries. It is believed that 60-80% of women are asymptomatic following OASI repair at 12 months but studies have shown that 17-24% developed worsening of faecal symptoms after a second vaginal delivery. The risk of recurrent OASI is believed to be 5-7 fold higher in women with a previous OASI, however the true recurrence is not exactly known due to various confounding factors. Methods We conducted a retrospective review of deliveries in two maternity units in the Mersey Deanery (UK), between 2007 and 2012 (29 706 deliveries). We identified 176 women who had sustained an OASI in a previous pregnancy who went on to have a subsequent delivery, (188 subsequent deliveries).The primary outcomes studied were mode of delivery and perineal injury sustained in the subsequent delivery.

Continue reading

Noorullah O.; Lekharaju V.P.; Din I.U.; Klcova J.; Cross T.; Evans J.; Sturgess R.; Palmer D.; Kumar P.; O’Grady E.; Stern N.; Journal of Hepatology, April 2014,

An external validation of the hepatoma arterial-embolisation prognosis (HAP) score: The Liverpool experience 

Citation: Journal of Hepatology, April 2014, vol./is. 60/1 SUPPL. 1(S401-S402), 0168-8278 (April 2014)

Author(s): Noorullah O.; Lekharaju V.P.; Din I.U.; Klcova J.; Cross T.; Evans J.; Sturgess R.; Palmer D.; Kumar P.; O’Grady E.; Stern N.

Abstract: Background and Aims: Most hepatocellular carcinomas (HCCs) have palliative treatment. Trans-arterial embolisation (TAE) or chemoembolisation (TACE) are used with variable results. The HAP score was recently described to determine patients likely to benefit from
TAE or TACE. We report our experience with TAE and TACE to assess whether the HAP score was valid for our cohort of patients. Methods: Retrospective review of cases given TAE or TACE in Liverpool, UK (2006-2013). HAP score [1 point each for albumin <36 g/dl, AFP >400 ng/ml, bilirubin >17 mumol/l, tumour diameter >7cm. HAP A = 0 points,
B = 1, C = 2, D> 2].

Source: EMBASE